[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350220-105":59,"doc-detail-350220-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","ajuba-the-master-regulator-bridging-emt-and-immune-evasion-in-colorectal-cancer","AJUBA - The Master Regulator Bridging EMT and Immune Evasion in Colorectal Cancer","","Epithelial–mesenchymal transition (EMT) drives metastatic dissemination and immune evasion in colorectal cancer (CRC), yet the molecular links to immune microenvironment remodeling remain unclear. This study identifies AJUBA as a key regulator connecting EMT with immune modulation in CRC. Integrating multi-cohort transcriptomics and single-cell RNA-seq, the work applies machine learning/deep learning to uncover EMT-associated prognostic genes, then validates AJUBA by mRNA/protein assays, functional knockdown, immune infiltration analysis, and spatial transcriptomics.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ajuba-the-master-regulator-bridging-emt-and-immune-evasion-in-colorectal-cancer/350220/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ajuba-the-master-regulator-bridging-emt-and-immune-evasion-in-colorectal-cancer/350220.png","ImageObject",300,407,{"name":92,"@type":93},"วิน","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What problem does the study address in colorectal cancer?","Question",{"text":113,"@type":114},"EMT promotes metastasis and immune evasion in CRC, but the mechanisms linking EMT to immune microenvironment changes are not well understood. The study targets this missing molecular connection.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was AJUBA identified and validated as an EMT-immune regulator?",{"text":118,"@type":114},"The study integrates multi-cohort transcriptomic datasets with single-cell RNA-seq, using machine learning and deep learning to find EMT-associated prognostic genes. AJUBA is then validated at mRNA and protein levels using qPCR, Western blotting, and IHC, followed by functional siRNA knockdown experiments.",{"name":120,"@type":111,"acceptedAnswer":121},"What biological and clinical effects are associated with AJUBA in CRC?",{"text":122,"@type":114},"AJUBA is upregulated and enriched in epithelial cells with EMT-activated features. Spatial analysis links AJUBA to cancer-associated fibroblast (CAF) colocalization in immune-excluded niches, correlating with M2 macrophage infiltration and VEGF/NOTCH signaling. Clinically, elevated AJUBA associates with advanced nodal metastasis and worse overall survival.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},350220,1790173896,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},2336475104736,"https://ap-avatar.wpscdn.com/avatar/22000c4c5e0e5b17e70?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786591360781797222","Mediators of Inflammation  \n SPECIAL ISSUE  Inflammation and Immune Signal Transduction at Single-Cell Resolution  \nRESEARCH ARTICLE OPEN ACCESS  \nAJUBA: The Master Regulator Bridging EMT and Immune Evasion in Colorectal Cancer  \nWenhui Shen1 | Minghui Cui2 | Xiaoqian Liao3 | Yuhan Xiong4 | Biji Zou3  | Xiaojun Zhang1  | Cuijie Shao5   \n1Department of Head Neck and Thyroid, The Afﬁliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou 450008,  \nChina | 2Shandong First Medical University, Taian 271000, China | 3Clinical Laboratory, The Third Afﬁliated Hospital of Sun Yat-Sen University, Guangzhou 510630, China | 4BASIS Bilingual School Shenzhen, Shenzhen 518000, China | 5Department of Medical Research Centor, Afﬁliated Hospital of Binzhou Medical University, Binzhou, China  \nCorrespondence: Biji Zou ([zoubj5@mail.sysu.edu.cn](zoubj5@mail.sysu.edu.cn)) | Xiaojun Zhang ([zlyyzhangxiaojun3563@zzu.edu.cn](zlyyzhangxiaojun3563@zzu.edu.cn)) | Cuijie Shao ([shaocuijie@163.com](shaocuijie@163.com))  \nReceived: 21 November 2025 | Revised: 23 December 2025 | Accepted: 12 February 2026  \nGuest Editor: Liu Jinhui  \nKeywords: AJUBA | colorectal cancer | overexpression | single-cell | spatial transcriptomics  \nABSTRACT  \nBackground: Epithelial–mesenchymal transition (EMT) represents a critical process that facilitates metastatic dissemination and immune evasion in colorectal cancer (CRC); however, the molecular factors that connect EMT to modiﬁcations in the immune microenvironment remain poorly elucidated. In this investigation, we identify AJUBA as an essential regulator that mediates the association between EMT and immune modulation in CRC.  \nMethods: By integrating multi-cohort transcriptomic datasets (The Cancer Genome Atlas (TCGA)-CRC, GSE18105, GSE22598, GSE89076, and GSE110224) with single-cell RNA-seq data (GSE132465), we applied machine learning and deep learning methodologies to comprehensively identify EMT-associated genes demonstrating prognostic signiﬁcance. AJUBA validation was performed at mRNA and protein levels in a cohort of 90 CRC patient samples using quantitative PCR, Western blotting, and immunohistochemical (IHC) approaches. Functional analyses involved siRNA-mediated knockdown experiments, coupled with evaluations of cell proliferation (CCK-8 assay), migration and invasion (transwell assay), clonogenic capacity (colony formation assay), and in vivo tumor growth in xenograft models. Immune inﬁltration was assessed via ssGSEA and CIBERSORT algorithms, and spatial transcriptomics data (GSE225857) were used to delineate AJUBA expression within tumor microdomains.  \nResults: Across multiple CRC cohorts, AJUBA exhibited marked upregulation and showed distinct enrichment in epithelial cells with activated EMT characteristics. Spatial transcriptomic proﬁling demonstrated AJUBA colocalization with cancer-associated ﬁbroblasts (CAFs) within immune-excluded niches. Enhanced AJUBA expression exhibited a positive correlation with heightened inﬁltration of M2 macrophages and activation of VEGF/NOTCH signaling cascades. In vivo, AJUBA knockdown led to suppressed tumor growth, reduced Ki-67 proliferation indices, and diminished M2 macrophage abundance. Clinically, elevated AJUBA expression correlated with advanced nodal metastasis and served as an independent predictor of poor overall survival (OS; HR = 4.809, 95% CI: 2.385–9.695, p\u003C 0:001) .  \nConclusions: AJUBA functions as a key regulator that links EMT to immune modulation, promoting macrophage polarization and facilitating immune evasion in CRC. Through its coupling of EMT activation with proangiogenic signaling, AJUBA represents both a prognostic biomarker and a promising therapeutic target for alleviating immune exclusion in metastatic CRC.  \n\n| Wenhui Shen, Minghui Cui, and Xiaoqian Liao should be listed as co-ﬁrst authors. |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution License, which permits use, d","cbCaisFbMEbbNYKY","https://ap.wps.com/l/cbCaisFbMEbbNYKY","pdf",12562331,33,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What problem does the study address in colorectal cancer?\",\"answer\":\"EMT promotes metastasis and immune evasion in CRC, but the mechanisms linking EMT to immune microenvironment changes are not well understood. The study targets this missing molecular connection.\"},{\"question\":\"How was AJUBA identified and validated as an EMT-immune regulator?\",\"answer\":\"The study integrates multi-cohort transcriptomic datasets with single-cell RNA-seq, using machine learning and deep learning to find EMT-associated prognostic genes. AJUBA is then validated at mRNA and protein levels using qPCR, Western blotting, and IHC, followed by functional siRNA knockdown experiments.\"},{\"question\":\"What biological and clinical effects are associated with AJUBA in CRC?\",\"answer\":\"AJUBA is upregulated and enriched in epithelial cells with EMT-activated features. Spatial analysis links AJUBA to cancer-associated fibroblast (CAF) colocalization in immune-excluded niches, correlating with M2 macrophage infiltration and VEGF/NOTCH signaling. Clinically, elevated AJUBA associates with advanced nodal metastasis and worse overall survival.\"}]","AJUBA - The Master Regulator Bridging EMT and Immune Evasion in Colorectal Cancer | PDF",1790087872,83,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2478a39c3fa082eacd9f1be640e22f15.webp",983,1291,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0d334e3243c361a5a1f17563556a4cca.webp",982,1290,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0b38a19c8a7cf23322d20eee8297a55f.webp",981,1289,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/60e5ccbacd070be96f250ba2e6bd6cdc.webp",980,1287]